E209 - Secondary prevention of acute coronary syndromes: a summary of the new 2025 Australian guideline
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
E209 - Secondary prevention of acute coronary syndromes: a summary of the new 2025 Australian guideline
-
Narrated by:
-
By:
Summary
Laura Beaton chats with David Brieger, head of cardiology at Concord Hospital, Sydney, about the 2025 Australian acute coronary syndromes [ACS] clinical guideline. David explains the importance of secondary prevention for ACS, including new approaches to tailoring the duration of dual antiplatelet therapies, new lipid targets, and the limited role of beta blockers and colchicine. Read the full article in Australian Prescriber.
adbl_web_anon_alc_button_suppression_c
No reviews yet